Glucose Intolerance  >>  pioglitazone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00328627 / 2006-000694-30: Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Checkmark P3 data
Mar 2012 - Mar 2012: P3 data
Checkmark P3 data
Mar 2012 - Mar 2012: P3 data
Completed
3
1554
US, Europe, RoW
Alogliptin, SYR-322, Alogliptin placebo, Pioglitazone, ACTOS®, Pioglitazone placebo
Takeda
Type 2 Diabetes Mellitus
03/08
03/08
NCT00220961: Actos Now for Prevention of Diabetes (ACT NOW)

Checkmark EASD 2013
Jul 2013 - Jul 2013: EASD 2013
Checkmark ADA 2013
Jun 2013 - Jun 2013: ADA 2013
Checkmark
More
Completed
3
602
US
Pioglitazone, Actos, Placebo
The University of Texas Health Science Center at San Antonio, University of Texas, Takeda Pharmaceuticals North America, Inc.
Impaired Glucose Tolerance, Type 2 Diabetes
04/10
04/10

Download Options